Bridging the valley of death
Professor Shaun Jackson is calling on the Australian Government to establish a Medical Research Future Fund (MRFF) clinical development fund to support the early clinical development of breakthrough medical devices and therapies.
HRI reviews colchicine for cardiovascular disease
HRI scientists and collaborators have reviewed colchicine and its potential as a treatment for cardiovascular disease, in a paper published in Heart, Lung and Circulation.
Solving a sticky problem in diabetes: Dr Lining (Arnold) Ju wins Ideas Grant
Congratulations to Dr Lining (Arnold) Ju on being awarded a 2020 Ideas Grant from the NHMRC for his project Novel ‘Mechano-medicine’ combats deadly sticky blood clots in diabetes.
Dr Jessica Orchard wins CSANZ Prevention Prize
HRI's Dr Jessica Orchard was awarded the Prevention Prize at the Cardiac Society of Australia & New Zealand conference for her talk on the AF-SMART II rural screening study.
HRI wins Best Workplace Award 2020
HRI has won ‘Best Workplace 2020’ for providing an exceptional work environment for staff, awarded by consultancy firm Voice Project.
HRI researchers take steps to prevent peripheral artery disease
HRI’s Arterial Inflammation and Redox Biology Group has made an important discovery in preventing peripheral artery disease.
HRI expands research into inflammation and blood pressure disorders
HRI is delighted to welcome Dr Christopher Stanley as lead of the Microvascular Research Group.
Global media interest in HRI’s breakthrough anti-clotting drug for COVID-19
The revolutionary new anti-clotting medicine developed by HRI has attracted global media interest due to its far-reaching impact.
Collaboration advancing medical research: Drs Anna Waterhouse and John O’Sullivan
Collaboration is essential to advancing medical research, so HRI are delighted that Drs Anna Waterhouse and John O’Sullivan and their multiple research collaborations are featured by the Charles Perkins Centre, The University of Sydney.